Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Universe Pharmaceuticals ( (UPC) ) has issued an update.
Universe Pharmaceuticals INC has received a delisting notice from Nasdaq as its share price fell below $1 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2). The company, which previously undertook a reverse stock split in November 2024, is not eligible for a compliance period and has until February 5, 2025, to appeal. If an appeal isn’t filed, trading will be suspended on February 7, 2025. The company is exploring options to regain compliance, including a potential reverse stock split.
More about Universe Pharmaceuticals
Universe Pharmaceuticals INC, based in Ji’an, Jiangxi, China, is a pharmaceutical company specializing in traditional Chinese medicine derivatives aimed at improving the well-being of the elderly. The company also distributes biomedical drugs, medical instruments, and dietary supplements across 30 provinces in China.
YTD Price Performance: -37.01%
Average Trading Volume: 2,329,994
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $851.8K
For detailed information about UPC stock, go to TipRanks’ Stock Analysis page.